Xiao-hui Zhou 周小辉

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Currently available monotherapies of oral nucleoside/nucleotide analogs or interferon are unable to achieve a sustained and effective response in most of patients with chronic hepatitis B (CHB). The objective of the present study was to compare the efficacy and safety of pegylated interferon (Peg-IFN) alpha-2b plus adefovir dipivoxil combination therapy(More)
  • 1